SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Serotoninergic mechanisms in the treatment of obsessive–compulsive disorder
16 references·7 citing·45 second hop
Serotoninergic mechanisms in the treatment of obsessive–compulsive disorder (2008)Serotoninergic mechanisms in the treatmen…Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice (2007)Cortico-striatal synaptic def…The Dimensional Yale–Brown Obsessive–Compulsive Scale (DY-BOCS): an instrument for assessing obsessive–compulsive symptom dimensions (2006)The Dimensional Yale–Brown Ob…Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder (2006)Safety, Tolerability, and Eff…Glutamate Transporter Gene SLC1A1 Associated With Obsessive-compulsive Disorder (2006)Glutamate Transporter Gene SL…A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder (2006)A systematic review: antipsyc…Riluzole Augmentation in Treatment-Resistant Obsessive–Compulsive Disorder: An Open-Label Trial (2005)Riluzole Augmentation in Trea…Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication (2005)Lifetime Prevalence and Age-o…Glutamatergic Dysfunction in OCD (2005)Glutamatergic Dysfunction in …A Multidimensional Model of Obsessive-Compulsive Disorder (2005)A Multidimensional Model of O…The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. (2004)The role of dopamine in obses…Reduced Anterior Cingulate Glutamatergic Concentrations in Childhood OCD and Major Depression Versus Healthy Controls (2004)Reduced Anterior Cingulate Gl…Decrease in Caudate Glutamatergic Concentrations in Pediatric Obsessive-Compulsive Disorder Patients Taking Paroxetine (2000)Decrease in Caudate Glutamate…A Double-blind, Placebo-Controlled Study of Risperidone Addition in Serotonin Reuptake Inhibitor–Refractory Obsessive-compulsive Disorder (2000)A Double-blind, Placebo-Contr…Haloperidol Addition in Fluvoxamine-Refractory Obsessive-Compulsive Disorder (1994)Haloperidol Addition in Fluvo…Serotonergic Function in Obsessive-Compulsive Disorder (1992)Serotonergic Function in Obse…Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? (1990)Beyond the serotonin hypothes…Obsessive‐compulsive disorder: Etiology, neuropathology, and cognitive dysfunction (2023)Obsessive‐compulsive disorder…Marble burying as compulsive behaviors in male and female mice (2017)Marble burying as compulsive …N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic Review (2015)N-Acetyl Cysteine in the Trea…Learning From Animal Models of Obsessive-Compulsive Disorder (2015)Learning From Animal Models o…Augmentation strategies in obsessive–compulsive disorder (2013)Augmentation strategies in ob…Current animal models of obsessive compulsive disorder: an update (2011)Current animal models of obse…Association of SLC6A4 variants with obsessive-compulsive disorder in a large multicenter US family study (2009)Association of SLC6A4 variant…A RATING SCALE FOR DEPRESSION (1960)The Yale-Brown Obsessive Compulsive Scale (1989)Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication (2005)The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems (2008)Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V (2010)Practice Parameter for the Assessment and Treatment of Children and Adolescents With Obsessive-Compulsive Disorder (2011)Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision (2008)The neurobiology of psychedelic drugs: implications for the treatment of mood disorders (2010)The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future (2017)THE ASSESSMENT OF ANXIETY STATES BY RATING (1959)Development of a Rating Scale for Primary Depressive Illness (1967)Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial Reliability and Validity Data (1997)Ten-Year Review of Rating Scales. II: Scales for Internalizing Disorders (2002)Invasive Circuitry-Based Neurotherapeutics: Stereotactic Ablation and Deep Brain Stimulation for OCD (2009)Brain circuitry of compulsivity (2015)The Yale-Brown Obsessive Compulsive Scale (1989)Efficacy and Tolerability of Serotonin Transport Inhibitors in Obsessive-compulsive Disorder (1995)Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative Review. (1997)Observing Interaction: An Introduction to Sequential Analysis (1988)The Epidemiology of Obsessive-Compulsive Disorder in Five US Communities (1988)Observing Interaction (1997)Obsessive–compulsive disorder: an integrative genetic and neurobiological perspective (2014)Neurobiology of rodent self-grooming and its value for translational neuroscience (2015)Obsessive-Compulsive Disorder: Puzzles and Prospects (2019)Children's Yale-Brown Obsessive Compulsive Scale: Reliability and Validity (1997)A Review and Meta-Analysis of the Genetic Epidemiology of Anxiety Disorders (2001)Early versus late onset obsessive–compulsive disorder: Evidence for distinct subtypes (2011)Evidence-based pharmacotherapy of obsessive-compulsive disorder (2012)Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS (2014)Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States (1994)Bias in meta-analysis detected by a simple, graphical test (1997)The Cochrane Library (2005)Clinical course of Tourette syndrome (2009)Child abuse: Adolescent records vs. adult recall (1990)The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) (2004)The Prevalence and Correlates of Eating Disorders in the National Comorbidity Survey Replication (2006)Abnormal and normal obsessions (1978)The Obsessive-Compulsive Inventory: Development and validation of a short version. (2002)Obsessive-compulsive disorder (2009)The Hierarchical Taxonomy of Psychopathology (HiTOP): A dimensional alternative to traditional nosologies. (2017)Obsessive–compulsive disorder (2019)ECDEU Assessment Manual for Psychopharmacology (1976)Treatment non-response in OCD: methodological issues and operational definitions (2002)Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment (2011)
this work references cited by second hop

References

  • 2005Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication20,388 cited
  • 2005A Multidimensional Model of Obsessive-Compulsive Disorder1,075 cited
  • 2007Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice851 cited
  • 2006Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder789 cited
  • 2006A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder635 cited
  • 2000A Double-blind, Placebo-Controlled Study of Risperidone Addition in Serotonin Reuptake Inhibitor–Refractory Obsessive-compulsive Disorder571 cited
  • 1994Haloperidol Addition in Fluvoxamine-Refractory Obsessive-Compulsive Disorder570 cited
  • 2006The Dimensional Yale–Brown Obsessive–Compulsive Scale (DY-BOCS): an instrument for assessing obsessive–compulsive symptom dimensions516 cited
  • 2000Decrease in Caudate Glutamatergic Concentrations in Pediatric Obsessive-Compulsive Disorder Patients Taking Paroxetine377 cited
  • 2006Glutamate Transporter Gene SLC1A1 Associated With Obsessive-compulsive Disorder357 cited
  • 2005Glutamatergic Dysfunction in OCD344 cited
  • 2005Riluzole Augmentation in Treatment-Resistant Obsessive–Compulsive Disorder: An Open-Label Trial314 cited
  • 1990Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

283 cited
  • 2004The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence.279 cited
  • 1992Serotonergic Function in Obsessive-Compulsive Disorder268 cited
  • 2004Reduced Anterior Cingulate Glutamatergic Concentrations in Childhood OCD and Major Depression Versus Healthy Controls246 cited
  • Cited by

    • 2023Obsessive‐compulsive disorder: Etiology, neuropathology, and cognitive dysfunction111 cited
    • 2015N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic Review96 cited
    • 2011Current animal models of obsessive compulsive disorder: an update82 cited
    • 2015Learning From Animal Models of Obsessive-Compulsive Disorder78 cited
    • 2009Association of SLC6A4 variants with obsessive-compulsive disorder in a large multicenter US family study77 cited
    • 2013Augmentation strategies in obsessive–compulsive disorder75 cited
    • 2017Marble burying as compulsive behaviors in male and female mice74 cited